You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Auto-Injector

Showing 1 - 25 of 805
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Rheumatoid Arthritis Trial (CT-P47 AI (tocilizumab), CT-P47 PFS (tocilizumab))

Not yet recruiting
  • Rheumatoid Arthritis
  • CT-P47 AI (tocilizumab)
  • CT-P47 PFS (tocilizumab)
  • (no location specified)
Feb 14, 2023

Healthy Subjects Trial in Seoul (CT-P47)

Recruiting
  • Healthy Subjects
  • CT-P47
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Nov 13, 2022

Healthy Volunteers Trial in Tempe, Lincoln (Nemolizumab)

Completed
  • Healthy Volunteers
  • Tempe, Arizona
  • +1 more
Dec 13, 2022

Healthy Volunteers Trial (Lecanemab)

Not yet recruiting
  • Healthy Volunteers
  • (no location specified)
Sep 6, 2022

Carotid Artery Stenosis Trial in London (Evolocumab Auto-Injector [Repatha], Placebo Auto-Injector)

Active, not recruiting
  • Carotid Artery Stenosis
  • Evolocumab Auto-Injector [Repatha]
  • Placebo Auto-Injector
  • London, United Kingdom
    Imperial College Healthcare NHS Trust
Oct 12, 2022

Healthy Participants Trial in Anaheim, Salt Lake City (BMS-986036)

Completed
  • Healthy Participants
  • Anaheim, California
  • +1 more
Mar 7, 2022

Healthy Volunteers Trial in Grayslake, Austin (Risankizumab)

Completed
  • Healthy Volunteers
  • Grayslake, Illinois
  • +1 more
Mar 9, 2022

Rheumatoid Arthritis Trial in Bydgoszcz (CT-P17 SC AI (adalimumab))

Completed
Has Results
  • Rheumatoid Arthritis
  • CT-P17 SC AI (adalimumab)
  • Bydgoszcz, Poland
    Nasz Lekarz Osrodek Badan Klinicznych
Oct 19, 2021

Diabetes, Type 2, Stroke (CVA) or Transient Ischemic Attack Trial in Seattle (Semaglutide Auto-Injector, Placebo)

Not yet recruiting
  • Diabetes Mellitus, Type 2
  • Stroke (CVA) or Transient Ischemic Attack
  • Semaglutide Auto-Injector
  • Placebo
  • Seattle, Washington
    University of Washington - Harborview Medical Center
Mar 10, 2023

Healthy Trial in Leeds (On-Body Delivery System (OBDS)/Multiple Bolus Injector, Single Auto Injector, Placebo)

Recruiting
  • Healthy
  • On-Body Delivery System (OBDS)/Multiple Bolus Injector
  • +2 more
  • Leeds, United Kingdom
    LABCORP
Jul 7, 2022

Healthy Subjects Trial in Overland Park (Selatogrel)

Completed
  • Healthy Subjects
  • Selatogrel
  • Overland Park, Kansas
    Altasciences Clinical Kansas, Inc
Nov 15, 2022

Status Epilepticus Trial in Raleigh (Midazolam, Seizalam)

Completed
  • Status Epilepticus
  • Raleigh, North Carolina
    Wake Research
Mar 2, 2022

Overdose Antidote Trial in Seattle (Naloxone HCl injection solution, SmartDose wearable auto injector and mobile respiratory

Completed
  • Overdose Antidote
  • Naloxone hydrochloride injection solution, SmartDose wearable auto injector and mobile respiratory sensing system
  • Seattle, Washington
    University of Washington
Oct 28, 2021

Anaphylactic Shock Trial in Metz (skin ultrasound)

Completed
  • Anaphylactic Shock
  • skin ultrasound
  • Metz, France
    Chr Metz Thionville
Aug 25, 2021

Asthma Trial in France (Pre-filled syringe, mepolizumab 100 mg/month, Auto-injector pen, mepolizumab 100 mg/month)

Not yet recruiting
  • Asthma
  • Pre-filled syringe, mepolizumab 100 mg/month
  • Auto-injector pen, mepolizumab 100 mg/month
  • Besançon, France
  • +7 more
Nov 15, 2022

Multiple Sclerosis, Erectile Dysfunction, Testosterone Deficiency Trial in New Orleans (XYOSTED 75 milligram (mg) in 0.5 ML

Not yet recruiting
  • Multiple Sclerosis
  • +2 more
  • XYOSTED 75 milligram (mg) in 0.5 ML Auto-Injector
  • New Orleans, Louisiana
    LSU Health Multispecilaity Clinics
Jul 19, 2022

Plaque Psoriasis Trial in Worldwide (Placebo 2 mL auto-injector, Placebo 1 mL prefilled syringe, Secukinumab 2 mL auto-injector)

Completed
Has Results
  • Plaque Psoriasis
  • Placebo 2 mL auto-injector
  • +3 more
  • Miami, Florida
  • +21 more
Oct 7, 2021

Psoriasis Trial in Philadelphia (Secukinumab Auto-Injector)

Enrolling by invitation
  • Psoriasis
  • Secukinumab Auto-Injector
  • Philadelphia, Pennsylvania
    Hospital at the University of Pennsylvania
Feb 11, 2022

Healthy Trial in Austin (CT-P17)

Completed
Has Results
  • Healthy
  • CT-P17
  • Austin, Texas
    PPD Development, LP
Jan 14, 2021

Systemic Lupus Erythematosus Trial in Shanghai (Belimumab for IV, Belimumab for SC)

Completed
Has Results
  • Systemic Lupus Erythematosus
  • Belimumab for IV
  • Belimumab for SC
  • Shanghai, China
    GSK Investigational Site
Nov 30, 2020

Chronic Plaque Psoriasis, Moderate to Severe Chronic Plaque Psoriasis Trial in Canada, United States (Bimekizumab)

Completed
  • Chronic Plaque Psoriasis
  • Moderate to Severe Chronic Plaque Psoriasis
  • Phoenix, Arizona
  • +38 more
Jan 6, 2022

Healthy Volunteers Trial in Baltimore, Berlin (Bimekizumab)

Completed
  • Healthy Volunteers
  • Baltimore, Maryland
  • +1 more
Jun 12, 2020

Pharmacokinetics, Epinephrine, Albuterol Trial in Cypress (Epinephrine (0.125 mg/inhalation), Epinephrine Injection

Completed
Has Results
  • Pharmacokinetics
  • +4 more
  • Epinephrine (0.125 mg/inhalation)
  • +2 more
  • Cypress, California
    Amphastar Study Site 0035
Mar 4, 2021

Rheumatoid Arthritis Trial (Etanercept)

Completed
  • Rheumatoid Arthritis
  • (no location specified)
Jan 17, 2020

Primary Hypercholesterolaemia and Mixed Dyslipidemia Trial in Beijing (JS002, Placebo)

Not yet recruiting
  • Primary Hypercholesterolaemia and Mixed Dyslipidemia
  • Beijing, Beijing, China
    Peking University Third Hospital
Nov 17, 2022